2-171324198-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001321154.2(METTL8):c.1198G>A(p.Val400Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000239 in 1,545,380 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001321154.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METTL8 | NM_001321154.2 | c.1198G>A | p.Val400Ile | missense_variant | 10/10 | ENST00000375258.9 | NP_001308083.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METTL8 | ENST00000375258.9 | c.1198G>A | p.Val400Ile | missense_variant | 10/10 | 5 | NM_001321154.2 | ENSP00000364407 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 151032Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000450 AC: 7AN: 155652Hom.: 0 AF XY: 0.0000485 AC XY: 4AN XY: 82510
GnomAD4 exome AF: 0.0000237 AC: 33AN: 1394348Hom.: 2 Cov.: 30 AF XY: 0.0000291 AC XY: 20AN XY: 687548
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151032Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73722
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.1198G>A (p.V400I) alteration is located in exon 10 (coding exon 9) of the METTL8 gene. This alteration results from a G to A substitution at nucleotide position 1198, causing the valine (V) at amino acid position 400 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at